CL2016001597A1 - Methods of treatment of women with hypoactive sexual desire disorders with combination treatment of bupropion and trazodone - Google Patents
Methods of treatment of women with hypoactive sexual desire disorders with combination treatment of bupropion and trazodoneInfo
- Publication number
- CL2016001597A1 CL2016001597A1 CL2016001597A CL2016001597A CL2016001597A1 CL 2016001597 A1 CL2016001597 A1 CL 2016001597A1 CL 2016001597 A CL2016001597 A CL 2016001597A CL 2016001597 A CL2016001597 A CL 2016001597A CL 2016001597 A1 CL2016001597 A1 CL 2016001597A1
- Authority
- CL
- Chile
- Prior art keywords
- treatment
- trazodone
- bupropion
- women
- methods
- Prior art date
Links
- 206010024419 Libido decreased Diseases 0.000 title 1
- 208000006262 Psychological Sexual Dysfunctions Diseases 0.000 title 1
- 229960001058 bupropion Drugs 0.000 title 1
- SNPPWIUOZRMYNY-UHFFFAOYSA-N bupropion Chemical compound CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 SNPPWIUOZRMYNY-UHFFFAOYSA-N 0.000 title 1
- 238000011284 combination treatment Methods 0.000 title 1
- 208000017020 hypoactive sexual desire disease Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229960003991 trazodone Drugs 0.000 title 1
- PHLBKPHSAVXXEF-UHFFFAOYSA-N trazodone Chemical compound ClC1=CC=CC(N2CCN(CCCN3C(N4C=CC=CC4=N3)=O)CC2)=C1 PHLBKPHSAVXXEF-UHFFFAOYSA-N 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662351904P | 2016-06-17 | 2016-06-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2016001597A1 true CL2016001597A1 (en) | 2017-10-06 |
Family
ID=57758862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2016001597A CL2016001597A1 (en) | 2016-06-17 | 2016-06-20 | Methods of treatment of women with hypoactive sexual desire disorders with combination treatment of bupropion and trazodone |
Country Status (9)
| Country | Link |
|---|---|
| KR (1) | KR20170142797A (en) |
| AR (2) | AR105087A1 (en) |
| AU (1) | AU2016204151A1 (en) |
| CA (1) | CA2933921A1 (en) |
| CL (1) | CL2016001597A1 (en) |
| MX (1) | MX2016008272A (en) |
| PE (1) | PE20180023A1 (en) |
| UY (1) | UY36742A (en) |
| WO (1) | WO2017218018A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5897864A (en) * | 1996-05-23 | 1999-04-27 | Cohen; Alan J. | Method for treating sexual dysfunction disorders with compositions containing ginkgo biloba |
| HUP0202719A3 (en) * | 2001-08-21 | 2006-01-30 | Pfizer Prod Inc | Pharmaceutical compositions for the treatment of female sexual dysfunctions |
| NZ551340A (en) * | 2004-04-22 | 2010-10-29 | Boehringer Ingelheim Int | Pharmaceutical composition comprising flibanserin and a melanocortin agonist for the treatment of premenstrual disorder or sexual aversion disorder |
| US20070225279A1 (en) * | 2006-03-24 | 2007-09-27 | Wyeth | Therapeutic combinations for the treatment of depression |
| AU2013299725A1 (en) * | 2012-08-06 | 2015-03-26 | S1 Biopharma, Inc. | Treatment regimens |
-
2016
- 2016-06-20 WO PCT/US2016/038386 patent/WO2017218018A1/en active Application Filing
- 2016-06-20 MX MX2016008272A patent/MX2016008272A/en unknown
- 2016-06-20 PE PE2016000848A patent/PE20180023A1/en unknown
- 2016-06-20 CA CA2933921A patent/CA2933921A1/en not_active Abandoned
- 2016-06-20 CL CL2016001597A patent/CL2016001597A1/en unknown
- 2016-06-20 UY UY0001036742A patent/UY36742A/en not_active Application Discontinuation
- 2016-06-20 AU AU2016204151A patent/AU2016204151A1/en not_active Abandoned
- 2016-06-20 KR KR1020160076915A patent/KR20170142797A/en not_active Application Discontinuation
- 2016-06-21 AR ARP160101856A patent/AR105087A1/en unknown
- 2016-06-21 AR ARP160101828A patent/AR105047A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UY36742A (en) | 2016-12-30 |
| PE20180023A1 (en) | 2018-01-09 |
| AR105047A1 (en) | 2017-08-30 |
| MX2016008272A (en) | 2017-12-18 |
| AU2016204151A1 (en) | 2018-01-18 |
| CA2933921A1 (en) | 2017-12-17 |
| WO2017218018A1 (en) | 2017-12-21 |
| KR20170142797A (en) | 2017-12-28 |
| AR105087A1 (en) | 2017-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262608A (en) | Combination treatment of ocular inflammatory disorders and diseases | |
| IL273693A (en) | Treatment of inflammatory disorders | |
| MA47095A (en) | PALAIS MOU TREATMENT | |
| EP3349783C0 (en) | Compositions and methods relating to the treatment of diseases | |
| DK3244965T3 (en) | TREATMENT OF HEADACHE WITH ELECTRICAL STIMULATION | |
| GB201517215D0 (en) | Use of cannabinoids in the treatment of inflammatory skin diseases | |
| IL275543A (en) | Intraductal methods of treatment of breast disorders | |
| PT3405215T (en) | Methods for the treatment of danon disease and other disorders of autophagy | |
| IL267229A (en) | Methods of treating ocular disorders | |
| GB201404403D0 (en) | Compositions and methods relating to the treatment of diseases | |
| MA46353A (en) | WOMEN'S INFERTILITY TREATMENT METHODS | |
| DK3548061T3 (en) | Treatment of neurological diseases | |
| FR3017298B1 (en) | CONJUGATES AND PRO-DRUGS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES | |
| IL264070A (en) | Methods and compositions for treatment of disorders and diseases involving rdh12 | |
| IL249894A0 (en) | Targeted therapeutic nanoparticles and methods of making and using same | |
| GB201618424D0 (en) | Treatment of antibody mediated disease | |
| FR3022139B1 (en) | NEW COMPOSITIONS FOR THE TREATMENT OF SKIN FLAVORS AND ROSACEA | |
| IL270362B (en) | Treatment of glaucoma | |
| ES1166384Y (en) | FEMALE SEXUAL STIMULATION DEVICE | |
| GB201607388D0 (en) | Treatment of impulsivity-related disorders | |
| GB201611413D0 (en) | Method of skin care | |
| IL260987A (en) | Treatment and diagnosis of inflammatory disorders | |
| CL2016001597A1 (en) | Methods of treatment of women with hypoactive sexual desire disorders with combination treatment of bupropion and trazodone | |
| BR112016028653A2 (en) | methods of treating neurodevelopmental diseases and disorders | |
| GB201604359D0 (en) | Treatment of tissue disorders |